
2.27 Delayed Data As of 3:29pm ET | ![]() Today’s Change | 1.52 Today|||52-Week Range 8.74 | -62.97% Year-to-Date |
Can-Fite (CANF) Up on Liver Cancer Study Update of Namodenoson Nov 22 / Zacks.com - Paid Partner Content |
Previous close | 2.38 |
Today’s open | 2.38 |
Day’s range | 2.27 - 2.40 |
Volume | 57,898 |
Average volume (3 months) | 62,851 |
Market cap | $9.4M |
Earnings growth (last year) | +54.82% |
Earnings growth (this year) | +25.91% |
Earnings growth (next 5 years) | +1.00% |
Revenue growth (last year) | -5.41% |
P/E ratio | NM |
Price/Sales | 20.66 |
Price/Book | 1.26 |
Today’s change | Today’s % change | |
---|---|---|
BNTCBenitec Biopharma In... | -0.12 | -3.77% |
ONVOOrganovo Holdings In... | -0.01 | -0.85% |
---- | ||
OTLCOncotelic Therapeuti... | -0.00 | -0.65% |
Last reporting date | November 28, 2023 |
EPS forecast (this quarter) | -$0.53 |
Annual revenue (last year) | $806.8K |
Annual profit (last year) | -$10.1M |
Net profit margin | -1,255.93% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Petach Tikva, Hamerkaz |